Acetyl-11-keto-β-boswellic acid ameliorates cognitive deficits and reduces amyloid-β levels in APPswe/PS1dE9 mice through antioxidant and anti-inflammatory pathways
- 25 February 2020
- journal article
- research article
- Published by Elsevier BV in Free Radical Biology & Medicine
- Vol. 150, 96-108
- https://doi.org/10.1016/j.freeradbiomed.2020.02.022
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81801044)
This publication has 68 references indexed in Scilit:
- Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathyRedox Biology, 2013
- Further insights into Alzheimer disease pathogenesisNature Reviews Neurology, 2013
- Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary cultureCell Death & Disease, 2011
- Boswellia serrata acts on cerebral edema in patients irradiated for brain tumorsCancer, 2011
- Probing the Biology of Alzheimer's Disease in MiceNeuron, 2010
- Alzheimer's DiseaseNew England Journal of Medicine, 2010
- Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2009
- Nuclear factor erythroid 2-related factor 2 protects against beta amyloidMolecular and Cellular Neuroscience, 2008
- Expression of Nrf2 in Neurodegenerative DiseasesJournal of Neuropathology and Experimental Neurology, 2007
- Determination of Boswellic Acids in Brain and Plasma by High-Performance Liquid Chromatography/Tandem Mass SpectrometryAnalytical Chemistry, 2005